- Home
- FFIC vs ABEO Comparison
FFIC vs ABEO Comparison
Compare FFIC & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFIC
- ABEO
- Stock Information
- Founded
- FFIC 1929
- ABEO 1974
- Country
- FFIC United States
- ABEO United States
- Employees
- FFIC N/A
- ABEO N/A
- Industry
- FFIC Major Banks
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- FFIC Finance
- ABEO Health Care
- Exchange
- FFIC Nasdaq
- ABEO Nasdaq
- Market Cap
- FFIC 408.4M
- ABEO 332.0M
- IPO Year
- FFIC 1995
- ABEO 1980
- Fundamental
- Price
- FFIC $12.66
- ABEO $7.13
- Analyst Decision
- FFIC
- ABEO Strong Buy
- Analyst Count
- FFIC 0
- ABEO 6
- Target Price
- FFIC N/A
- ABEO $18.17
- AVG Volume (30 Days)
- FFIC 291.4K
- ABEO 659.6K
- Earning Date
- FFIC 07-24-2025
- ABEO 08-14-2025
- Dividend Yield
- FFIC 6.95%
- ABEO N/A
- EPS Growth
- FFIC N/A
- ABEO N/A
- EPS
- FFIC N/A
- ABEO 0.99
- Revenue
- FFIC $137,137,000.00
- ABEO $400,000.00
- Revenue This Year
- FFIC $110.74
- ABEO N/A
- Revenue Next Year
- FFIC $7.28
- ABEO $322.37
- P/E Ratio
- FFIC N/A
- ABEO $7.21
- Revenue Growth
- FFIC N/A
- ABEO N/A
- 52 Week Low
- FFIC $10.65
- ABEO $3.93
- 52 Week High
- FFIC $18.59
- ABEO $7.54
- Technical
- Relative Strength Index (RSI)
- FFIC 56.60
- ABEO 66.56
- Support Level
- FFIC $11.77
- ABEO $6.21
- Resistance Level
- FFIC $13.05
- ABEO $6.94
- Average True Range (ATR)
- FFIC 0.32
- ABEO 0.30
- MACD
- FFIC 0.08
- ABEO 0.05
- Stochastic Oscillator
- FFIC 73.65
- ABEO 71.32
About FFIC Flushing Financial Corporation
Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.